Ernexa Therapeutics, Inc. (ERNA)
12.46
+1.06
(+9.30%)
USD |
NASDAQ |
May 21, 16:00
12.42
-0.04
(-0.32%)
After-Hours: 07:41
Ernexa Therapeutics Shareholders Equity (Quarterly) : 6.859M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Quince Therapeutics, Inc. | 15.67M |
| Recursion Pharmaceuticals, Inc. | 1.025B |
| Tango Therapeutics, Inc. | 391.51M |
| Aprea Therapeutics, Inc. | 42.82M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.54M |
| Total Liabilities (Quarterly) | 3.684M |
| Debt to Equity Ratio | 0.0567 |
| Current Ratio | 2.892 |
| Net Debt Paydown Yield | 1.02% |